Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001191248-12-000002
Filing Date
2012-12-05
Accepted
2012-12-05 17:23:10
Documents
1
Period of Report
2012-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3509
  Complete submission text file 0001191248-12-000002.txt   4827
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02149
Business Address
BEST LAWRENCE C (Reporting) CIK: 0001191248 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 121244232